JP2001507344A - 抗体を産生するカプセル封入細胞 - Google Patents
抗体を産生するカプセル封入細胞Info
- Publication number
- JP2001507344A JP2001507344A JP52835398A JP52835398A JP2001507344A JP 2001507344 A JP2001507344 A JP 2001507344A JP 52835398 A JP52835398 A JP 52835398A JP 52835398 A JP52835398 A JP 52835398A JP 2001507344 A JP2001507344 A JP 2001507344A
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- cells
- antibody
- antibodies
- capsules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.抗体産生細胞をカプセル封入するカプセルであって、前記細胞を含有する コアと、前記コアを取り囲み、且つ前記細胞により産生された抗体を通過可能で ある多孔性カプセル壁とを備えたカプセル。 2.前記多孔性カプセル壁が、反対電荷のポリ電解質から形成されたポリ電解 質複合体から成る請求項1記載のカプセル。 3.前記多孔性カプセル壁が、硫酸セルロースおよびポリジメチルジアリルア ンモニウムから形成された複合体から成る請求項2記載のカプセル。 4.前記細胞が、クローン抗体を産生するように遺伝的に改変された請求項1 ないし3記載のカプセル。 5.前記抗体が、免疫グロブリンのIgA、IgM、IgG、IgDまたはIgEクラスに属 する請求項1ないし4記載のカプセル。 6.請求項1ないし5記載のカプセルであって、前記抗体が、 ウイルス感染細胞の表面上にあるウイルス表面マーカー がん細胞 自己免疫疾患の病理学的効果に関与するTまたはBリンパ球 寄生生物の表面マーカーまたは 有害効果を伴って循環する抗原 に結合し、前記細胞に対して細胞増殖抑制性または細胞毒性効果を示す抗体から 選択されるか、または、 前記抗体が、ウイルスの細胞感染に必要なウイルスレセプターに結合し阻害す る抗体、ウイルスへの結合を介した直接的な中和効果を有する抗体もしくは循環 する有害抗原に対する直接的な中和効果を有する抗体から選択されるカプセル。 7.請求項1ないし6記載のカプセルの、前記カプセルから放出された抗体に 応答する病気または疾患を治療するための、ヒトを含めた動物生体への移植のた めの使用。 8.皮下移植のための請求項7記載の使用。 9.請求項1ないし6記載のカプセルの、前記カプセルから放出された抗体に 応答する病気または疾患を治療する薬学的組成物を産生するための使用。 10.請求項1ないし6記載のカプセルを含有し、前記カプセルから治療上有 効な量で放出された抗体に応答する病気または疾患を治療するための薬学的組成 物。 11.請求項1ないし6記載のカプセル封入細胞により産生された抗体に応答 する疾患または病気の治療方法であって、前記カプセルおよび/または請求項1 0記載の薬学的組成物の、ヒトを含めた動物生体への移植を含む方法。。 12.皮下移植を含む請求項11記載の方法。 13.がんもしくは自己免疫疾患を治療するか、または寄生生物もしくは病原 性ウイルスによる感染を治療もしくは防御する請求項11または12記載の方法 。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK1497/96 | 1996-12-23 | ||
DK149796 | 1996-12-23 | ||
PCT/EP1997/007120 WO1998027966A2 (en) | 1996-12-23 | 1997-12-18 | Encapsulated cells producing antibodies |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008259300A Division JP2009013182A (ja) | 1996-12-23 | 2008-10-06 | 抗体を産生するカプセル封入細胞 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2001507344A true JP2001507344A (ja) | 2001-06-05 |
JP2001507344A5 JP2001507344A5 (ja) | 2005-07-14 |
JP4727768B2 JP4727768B2 (ja) | 2011-07-20 |
Family
ID=8105461
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52835398A Expired - Fee Related JP4727768B2 (ja) | 1996-12-23 | 1997-12-18 | 抗体を産生するカプセル封入細胞 |
JP2008259300A Pending JP2009013182A (ja) | 1996-12-23 | 2008-10-06 | 抗体を産生するカプセル封入細胞 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008259300A Pending JP2009013182A (ja) | 1996-12-23 | 2008-10-06 | 抗体を産生するカプセル封入細胞 |
Country Status (11)
Country | Link |
---|---|
US (1) | US6426088B1 (ja) |
EP (1) | EP0948319B1 (ja) |
JP (2) | JP4727768B2 (ja) |
AT (1) | ATE252374T1 (ja) |
AU (1) | AU6205998A (ja) |
DE (1) | DE69725754T2 (ja) |
DK (1) | DK0948319T3 (ja) |
ES (1) | ES2208973T3 (ja) |
PT (1) | PT948319E (ja) |
SI (1) | SI0948319T1 (ja) |
WO (1) | WO1998027966A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008533231A (ja) * | 2005-03-11 | 2008-08-21 | オーストリアノバ バイオテクノロジー ゲーエムベーハー | 特性の改良された硫酸セルロースを製造する方法 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020168339A1 (en) * | 1997-01-20 | 2002-11-14 | Marc Piechaczyk | Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same |
US6261281B1 (en) | 1997-04-03 | 2001-07-17 | Electrofect As | Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
DE60137430D1 (de) * | 2000-07-29 | 2009-03-05 | Smith & Nephew | Gewebeimplant zur wiederherstellung von knorpelgewebe |
US20040016013A1 (en) * | 2002-07-18 | 2004-01-22 | Gonzalo Hortelano | Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
US20040014704A1 (en) * | 2002-07-18 | 2004-01-22 | Gonzalo Hortelano | Oral administration of therapeutic agent coupled to transporting agent induces tolerance |
US20040014698A1 (en) * | 2002-07-18 | 2004-01-22 | Gonzalo Hortelano | Oral administration of therapeutic agent coupled to transporting agent |
US20040219099A1 (en) * | 2003-05-02 | 2004-11-04 | Jasbir Sandhu | Method for the treatment of tumors |
US20040220085A1 (en) * | 2003-05-02 | 2004-11-04 | Jasbir Sandhu | Compositions for nucleic acid delivery |
US20050208032A1 (en) * | 2004-01-16 | 2005-09-22 | Gonzalo Hortelano | Oral administration of therapeutic agent coupled to transporting agent |
MY175316A (en) | 2011-01-25 | 2020-06-19 | Austrianova Singapore Pte Ltd | Protection of microbial cells from acidic degradation |
GB201408233D0 (en) | 2014-05-09 | 2014-06-25 | Austrianova Singapore Pte Ltd | Use of polyanionic composition |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6025929A (ja) * | 1983-07-20 | 1985-02-08 | ザ・スト−ル・リサ−チ・アンド・デイベロツプメント・コ−ポレ−シヨン | カプセル化細胞、その製造方法および用途 |
ATE76331T1 (de) | 1987-02-25 | 1992-06-15 | Hoechst Ag | Mikroenkapsulierung von biologisch aktivem material. |
US5427935A (en) * | 1987-07-24 | 1995-06-27 | The Regents Of The University Of Michigan | Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes |
US5116747A (en) | 1989-08-11 | 1992-05-26 | University Of Waterloo | Immobilization of biologically active material in capsules prepared from a water-soluble polymer and chitosan acetate |
US5686113A (en) * | 1995-03-21 | 1997-11-11 | Temple University Of The Commonwealth System Of Higher Education | Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses |
US5997900A (en) * | 1996-04-17 | 1999-12-07 | Wang; Taylor G. | Encapsulation system for the immunoisolation of living cells |
-
1997
- 1997-12-18 US US09/331,447 patent/US6426088B1/en not_active Expired - Lifetime
- 1997-12-18 AU AU62059/98A patent/AU6205998A/en not_active Abandoned
- 1997-12-18 DK DK97954822T patent/DK0948319T3/da active
- 1997-12-18 JP JP52835398A patent/JP4727768B2/ja not_active Expired - Fee Related
- 1997-12-18 SI SI9730601T patent/SI0948319T1/xx unknown
- 1997-12-18 DE DE69725754T patent/DE69725754T2/de not_active Expired - Lifetime
- 1997-12-18 PT PT97954822T patent/PT948319E/pt unknown
- 1997-12-18 WO PCT/EP1997/007120 patent/WO1998027966A2/en active IP Right Grant
- 1997-12-18 EP EP97954822A patent/EP0948319B1/en not_active Expired - Lifetime
- 1997-12-18 AT AT97954822T patent/ATE252374T1/de active
- 1997-12-18 ES ES97954822T patent/ES2208973T3/es not_active Expired - Lifetime
-
2008
- 2008-10-06 JP JP2008259300A patent/JP2009013182A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008533231A (ja) * | 2005-03-11 | 2008-08-21 | オーストリアノバ バイオテクノロジー ゲーエムベーハー | 特性の改良された硫酸セルロースを製造する方法 |
Also Published As
Publication number | Publication date |
---|---|
WO1998027966A2 (en) | 1998-07-02 |
DK0948319T3 (da) | 2004-02-09 |
ATE252374T1 (de) | 2003-11-15 |
EP0948319A2 (en) | 1999-10-13 |
SI0948319T1 (en) | 2004-04-30 |
ES2208973T3 (es) | 2004-06-16 |
WO1998027966A3 (en) | 1998-11-12 |
JP4727768B2 (ja) | 2011-07-20 |
DE69725754T2 (de) | 2004-08-19 |
US6426088B1 (en) | 2002-07-30 |
AU6205998A (en) | 1998-07-17 |
PT948319E (pt) | 2004-02-27 |
EP0948319B1 (en) | 2003-10-22 |
JP2009013182A (ja) | 2009-01-22 |
DE69725754D1 (de) | 2003-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009013182A (ja) | 抗体を産生するカプセル封入細胞 | |
US10449151B2 (en) | Artificial cell constructs for cellular manipulation | |
US5192537A (en) | Method of treating renal cell carcinoma using activated mononuclear cells, renal tumor antigen and cimetidine | |
RU2268735C1 (ru) | Композиции подвергнутых рестрикции клеток, способных к быстрому росту, которые продуцируют вещества, подавляющие пролиферацию клеток, и их применение | |
US5916790A (en) | Encapsulation compositions, and methods | |
US6287558B1 (en) | Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule | |
US7615211B2 (en) | CD70 inhibition for the treatment and prevention of inflammatory bowel disease | |
ZA200503534B (en) | Implantation of encapsulated biological materials for treating diseases | |
JPH0534946B2 (ja) | ||
JPH09510868A (ja) | マクロカプセル化分泌腺細胞 | |
US20140017304A1 (en) | Method for encapsulated therapeutic products and uses thereof | |
US5888497A (en) | Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation | |
WO1991007951A1 (en) | Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same | |
JP2009533340A (ja) | 細胞移植片のための複数膜の免疫隔離システム | |
EP1382346B1 (en) | Conditioned medium and diffusible biological product produced by incubating entrapped cells | |
Eliason et al. | Proliferation of vascular endothelial cells stimulated in vitro by corneal epithelium. | |
JP2021516052A (ja) | 胸腺組織に由来する制御性t細胞を入手する方法および免疫系障害における細胞免疫療法としての前記細胞の使用 | |
RU2173986C2 (ru) | Имплантируемые агарозно-коллагеновые шарики, содержащие клетки, которые продуцируют способный к диффузии биологический продукт, и их применение | |
Yoshida et al. | Immunosuppressive Effect of the Depletion of Circulating Lymphocytes by Chronic Irradiation of the Rat Spleen | |
CN117186424A (zh) | 一种基于右旋糖酐基和两性离子基的水凝胶递送系统及抗肿瘤制剂 | |
JPH06121672A (ja) | 免疫反応性細胞の製造 | |
JPH08507747A (ja) | 生物学的活性物質用の細包を保護し生体に適合する、再利用可能なマクロカプセル封入システム | |
Sadovnic et al. | Isolation and characterization of chicken mesangial cells | |
MXPA01002927A (en) | Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20040826 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041021 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041021 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20071025 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20071025 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071120 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080130 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080415 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080715 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081006 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20081120 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20090416 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091027 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20091106 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20110404 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110414 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140422 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |